Tamoxifen, a Selective Estrogen Receptor Modulator (SERM), functions as an anti-estrogen [24, 25] and is a widely used adjuvant treatment for patients with early-stage ER positive breast cancer [26, 27]. The gene discussed is ESR1; the disease is breast carcinoma.